Lexaria Bioscience Corp. (LEXX)
0.6318
-0.02
(-3.01%)
USD |
NASDAQ |
Feb 23, 16:00
0.6361
0.00 (0.00%)
After-Hours: 19:59
Lexaria Bioscience Research and Development Expense (Quarterly) : 0.6713M for Nov. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 5.457M |
| Aurinia Pharmaceuticals, Inc. | 8.435M |
| Edesa Biotech, Inc. | 1.125M |
| Xenon Pharmaceuticals, Inc. | 76.41M |
| ProMIS Neurosciences, Inc. | 9.797M |